Volansi raises $50 million in Series B Funding to speed up middle-mile drone deliveries
VTOL drone manufacturer Volansi has closed $50 million in a Series B round of funding, allowing the company to expand its team and launch new projects in emerging markets in the USA and across the world.
In an announcement made today (Tuesday), this financing round was led by Icon Ventures and included new investors Harpoon Ventures and Merck Global Health Innovation Fund. Existing investors Lightspeed Venture Partners and YCombinator were also among the participants.
In addition to the company’s funding, Volansi has also announced Joe Horowitz, Managing Partner of Icon, and Barry Eggers, Founding Partner of Lightspeed, will both join its Board of Directors.
Hannan Parvizian, CEO and Co-Founder of Volansi, said: “The combination of our best in class cargo drones and unique software platform set us apart from others in the industry.
“Closing our Series B with such high-quality investors, especially during these challenging times, is further testament to the venture capital community’s confidence in our business and will allow us to keep pushing the envelope of mobility and robotics.”
Volansi provides automated point-to-point drone delivery services for time-critical parts and urgent medical supplies for enterprise customers and the U.S. Department of Defense.
With $25 million of prior capital provided by Lightspeed and other investors, Volansi developed and brought to market first-of-their-kind autonomous drones, the VOLY M20 and VOLY C10.
The VOLY C10 can carry up to 10-pounds of cargo over 50 miles and has already performed operations in Africa, the Caribbean, and the US.
While the VOLY M20 is a dual role aircraft with the ability to simultaneously carry up to 20-pounds of cargo, in addition to 10-pounds of sensor payloads. It has a 350-mile range, a cruising speed of 75 mph, and more than eight hours of endurance for sensor operations.
Horowitz said: “The drone market is very crowded with all sorts of players, but after getting to know Hannan and his team and doing an extensive amount of due diligence, especially with Volansi’s key customers and distribution partners, it became abundantly clear that the company is well-positioned to rapidly build a huge business.
“We are particularly excited about Volansi’s unique ability to address the medical community with urgent vaccine delivery, particularly in looking ahead to a post-COVID world.”
Eggers added: “The Volansi team has made significant progress since Lightspeed led the company’s Series A back in 2019. We’ve been impressed by the leadership and team’s ability to innovate and execute, and we are looking forward to deepening our partnership during this next phase of growth.”
For more information about Volansi and its drones, visit https://volansi.com/